{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:22:44Z","timestamp":1790997764849,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021077","name":"Kerman University of Medical Sciences Vice Chancellor of Research and Technology","doi-asserted-by":"publisher","award":["98000753"],"award-info":[{"award-number":["98000753"]}],"id":[{"id":"10.13039\/501100021077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasite Epidemiology and Control"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.parepi.2025.e00413","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:26:47Z","timestamp":1737678407000},"page":"e00413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification of C\u03b2S and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling"],"prefix":"10.1016","volume":"28","author":[{"given":"Farzaneh","family":"Zarrinkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Tavakoli Oliaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Afgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Molaakbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Bamorovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Salarkia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parepi.2025.e00413_bb0005","series-title":"Global report on neglected tropical diseases","author":"\"World Health Organization","year":"2023"},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0010","first-page":"8","article-title":"The emergence of anthroponotic cutaneous leishmaniasis following the earthquake in southern villages of Bam district, southeastern Iran, 2010","volume":"7","author":"Aflatoonian","year":"2013","journal-title":"J. Arthropod. Borne Dis."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089043","article-title":"A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran","volume":"9","author":"Aflatoonian","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.parepi.2025.e00413_bb0020","first-page":"271","article-title":"A review of impact of bam earthquake on cutaneous leishmaniasis and status: epidemic of old foci, emergence of new foci and changes in features of the disease","volume":"10","author":"Aflatoonian","year":"2016","journal-title":"J. Arthropod. Borne Dis."},{"issue":"6","key":"10.1016\/j.parepi.2025.e00413_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007423","article-title":"Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran","volume":"13","author":"Aflatoonian","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0030","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.abb.2004.08.024","article-title":"The enzymology of cystathionine biosynthesis: strategies for the control of substrate and reaction specificity","volume":"433","author":"Aitken","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.parepi.2025.e00413_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.parepi.2025.e00413_bb0040","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1128\/AAC.00768-16","article-title":"Silver and nitrate oppositely modulate antimony susceptibility through aquaglyceroporin 1 in Leishmania (Viannia) species","volume":"60","author":"Andrade","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4467","key":"10.1016\/j.parepi.2025.e00413_bb0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.6775372","article-title":"Polyamine metabolism: a potential therapeutic target in trypanosomes","volume":"210","author":"Bacchi","year":"1980","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.parepi.2025.e00413_bb0050","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parepi.2025.e00413_bb0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.micpath.2018.01.021","article-title":"Leishmania tropica isolates from non-healed and healed patients in Iran: A molecular typing and phylogenetic analysis","volume":"116","author":"Bamorovat","year":"2018","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192236","article-title":"Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran","volume":"13","author":"Bamorovat","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.parepi.2025.e00413_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.intimp.2019.02.008","article-title":"Host\u2019s immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways","volume":"69","author":"Bamorovat","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.parepi.2025.e00413_bb0070","doi-asserted-by":"crossref","first-page":"638957","DOI":"10.3389\/fmicb.2021.638957","article-title":"Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: a focus on anthroponotic form due to Leishmania tropica","volume":"12","author":"Bamorovat","year":"2021","journal-title":"Front.Microbiol."},{"issue":"7","key":"10.1016\/j.parepi.2025.e00413_bb0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1179\/136485906X118495","article-title":"Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia","volume":"100","author":"Bermudez","year":"2006","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BJ20110362","article-title":"Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities","volume":"438","author":"Birkholtz","year":"2011","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13071-024-06381-8","article-title":"Cutaneous leishmaniasis in sub-Saharan Africa: a systematic review of Leishmania species, vectors and reservoirs","volume":"17","author":"Blaizot","year":"2024","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.01236-08","article-title":"Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host","volume":"77","author":"Boitz","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parepi.2025.e00413_bb0095","article-title":"Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review","volume":"22","author":"Chhajed","year":"2023","journal-title":"Lancet Reg. Health-Southeast Asia"},{"issue":"11","key":"10.1016\/j.parepi.2025.e00413_bb0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","article-title":"Monitoring drug resistance in leishmaniasis","volume":"6","author":"Croft","year":"2001","journal-title":"Trop. Med. Int. Health"},{"issue":"10","key":"10.1016\/j.parepi.2025.e00413_bb0105","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.parepi.2025.e00413_bb0115","doi-asserted-by":"crossref","unstructured":"T. F. de Almeida, E. F. Cunha-Junior, J. L. M. Wanderley, J. D. S. Pacheco, L. H. Pinto-da-Silva, V. V. Andrade-Neto, et al., \"Strategies in the drug discovery and development for leishmaniasis: immunomodulators, natural products, synthetic compounds, and drug repositioning,\" 14, ed: Frontiers Media SA, 2024, 1384244.","DOI":"10.3389\/fcimb.2024.1384244"},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001514","article-title":"Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background","volume":"6","author":"Decuypere","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.parepi.2025.e00413_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001167","article-title":"Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis","volume":"5","author":"do Monte-Neto","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parepi.2025.e00413_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-5-276","article-title":"Leishmania development in sand flies: parasite-vector interactions overview","volume":"5","author":"Dost\u00e1lov\u00e1","year":"2012","journal-title":"Parasit. Vectors"},{"issue":"5","key":"10.1016\/j.parepi.2025.e00413_bb0135","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/AAC.49.5.1988-1993.2005","article-title":"Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes","volume":"49","author":"El Fadili","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4693","key":"10.1016\/j.parepi.2025.e00413_bb0140","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1126\/science.3883489","article-title":"Trypanothione: a novel bis (glutathionyl) spermidine cofactor for glutathione reductase in trypanosomatids","volume":"227","author":"Fairlamb","year":"1985","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/revic-2012-0006","article-title":"Chemistry of antimony-based drugs in biological systems and studies of their mechanism of action","volume":"33","author":"Frezard","year":"2013","journal-title":"Rev. Inorg. Chem."},{"issue":"5","key":"10.1016\/j.parepi.2025.e00413_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0155","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2958.1999.01634.x","article-title":"Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania","volume":"34","author":"Haimeur","year":"1999","journal-title":"Mol. Microbiol."},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-6851(00)00187-0","article-title":"Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae","volume":"108","author":"Haimeur","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"issue":"9","key":"10.1016\/j.parepi.2025.e00413_bb0165","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/ijd.13321","article-title":"Expression analysis of activated protein kinase C gene (LACK 1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR","volume":"55","author":"Hajjaran","year":"2016","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0170","first-page":"156","article-title":"The efficacy, relapse and failure in the treatment of anthroponotic cutaneous leishmaniosis with intralesional glucantime along with cryotherapy","volume":"23","author":"Karvar","year":"2016","journal-title":"J. Kerman Univ. Med. Sci."},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0175","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1550-7408.1986.tb05654.x","article-title":"Effects of DL-Alpha-Difluoromethylornithine on Leishmania donovani Promastigotes 1","volume":"33","author":"Kaur","year":"1986","journal-title":"J. Protozool."},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0180","first-page":"544","article-title":"Clinical features of anthroponotic cutaneous leishmaniasis in a major focus, Southeastern Iran, 1994\u20132014","volume":"12","author":"Khosravi","year":"2017","journal-title":"Iran. J. Parasitol."},{"issue":"11","key":"10.1016\/j.parepi.2025.e00413_bb0185","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","article-title":"Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism","volume":"1780","author":"Krauth-Siegel","year":"2008","journal-title":"Biochim. et Biophys. Acta (BBA)-General Subj."},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00436-012-2823-z","article-title":"Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani","volume":"111","author":"Kumar","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parepi.2025.e00413_bb0195","series-title":"Leishmaniasis, World Health Organization, Key Facts","year":"2023"},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"12","key":"10.1016\/j.parepi.2025.e00413_bb0205","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1017\/S0031182007003150","article-title":"Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony","volume":"134","author":"Mandal","year":"2007","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/labmed\/lmac134","article-title":"Review of the clinical presentation, pathology, diagnosis, and treatment of leishmaniasis","volume":"54","author":"Mathison","year":"2023","journal-title":"Lab. Med."},{"issue":"5","key":"10.1016\/j.parepi.2025.e00413_bb0215","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","article-title":"Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages","volume":"50","author":"Mookerjee Basu","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkl494","article-title":"Role of ABC transporter MRPA, \u03b3-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani","volume":"59","author":"Mukherjee","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"19","key":"10.1016\/j.parepi.2025.e00413_bb0225","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.1073\/pnas.93.19.10383","article-title":"Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania","volume":"93","author":"Mukhopadhyay","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.parepi.2025.e00413_bb0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1471-4922(01)01908-0","article-title":"Targeting polyamines of parasitic protozoa in chemotherapy","volume":"17","author":"M\u00fcller","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.parepi.2025.e00413_bb0235","first-page":"161","article-title":"Metal-Based Antiparasitic","volume":"16","author":"Navarro","year":"2024","journal-title":"Trace Metal. Infect. Diseas."},{"issue":"6","key":"10.1016\/j.parepi.2025.e00413_bb0240","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/tmi.13062","article-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling","volume":"23","author":"Oliaee","year":"2018","journal-title":"Trop. Med. Int. Health"},{"issue":"6","key":"10.1016\/j.parepi.2025.e00413_bb0245","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4269\/ajtmh.1997.57.651","article-title":"A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years)","volume":"57","author":"Oliveira-Neto","year":"1997","journal-title":"American J. Trop. Med. Hygi."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/BA20050023","article-title":"Identification of trypanothione from the human pathogen Entamoeba histolytica by mass spectrometry and chemical analysis","volume":"42","author":"Ondarza","year":"2005","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"3","key":"10.1016\/j.parepi.2025.e00413_bb0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"American J. Trop. Med. Hygi."},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0260","first-page":"123","article-title":"Identification of nonresponsive isolates to Glucantime in patients with cutaneous Leishmanaisis in Bam","volume":"18","author":"Pour","year":"2011","journal-title":"J. Kerman Univ. Med. Sci."},{"issue":"9","key":"10.1016\/j.parepi.2025.e00413_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074862","article-title":"Role of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovani","volume":"8","author":"Rai","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.parepi.2025.e00413_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150406","article-title":"Visceral leishmaniasis in Southwestern Iran: a retrospective clinico-hematological analysis of 380 consecutive hospitalized cases (1999\u20132014)","volume":"11","author":"Sarkari","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.parepi.2025.e00413_bb0275","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1568026023393048","article-title":"Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development","volume":"2","author":"Schmidt","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.parepi.2025.e00413_bb0280","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1074\/jbc.M005423200","article-title":"Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani","volume":"276","author":"Shaked-Mishan","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.parepi.2025.e00413_bb0285","first-page":"299","article-title":"A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article","volume":"44","author":"Sharifi","year":"2015","journal-title":"Iran. J. Public Health"},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0290","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AAC.01055-06","article-title":"Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion","volume":"51","author":"Singh","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"27","key":"10.1016\/j.parepi.2025.e00413_bb0295","doi-asserted-by":"crossref","first-page":"25120","DOI":"10.1074\/jbc.M301975200","article-title":"Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes","volume":"278","author":"Sudhandiran","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.parepi.2025.e00413_bb0300","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"issue":"4","key":"10.1016\/j.parepi.2025.e00413_bb0305","first-page":"503","article-title":"Metabolism of sulfur amino acids in Saccharomyces cerevisiae","volume":"61","author":"Thomas","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.parepi.2025.e00413_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107190","article-title":"Insights into the trypanothione system in antimony-resistant and sensitive Leishmania tropica clinical isolates","volume":"254","author":"Valashani","year":"2024","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.parepi.2025.e00413_bb0315","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.freeradbiomed.2011.05.011","article-title":"Leishmania\u2013macrophage interactions: Insights into the redox biology","volume":"51","author":"Van Assche","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.parepi.2025.e00413_bb0320","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1016\/S1473-3099(23)00353-5","article-title":"The status of combination therapy for visceral leishmaniasis: An updated review","volume":"24","author":"van Griensven","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.parepi.2025.e00413_bb0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bcp.2005.10.043","article-title":"Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukaemia monocyte cell line","volume":"71","author":"Wyllie","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"38","key":"10.1016\/j.parepi.2025.e00413_bb0330","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani","volume":"279","author":"Wyllie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.parepi.2025.e00413_bb0335","article-title":"Finishing the task of eliminating neglected tropical diseases (NTDs) in WHO South-East Asia Region: promises kept, challenges, and the way forward","volume":"18","author":"Yajima","year":"2023","journal-title":"Lancet Reg. Health-Southeast Asia"}],"container-title":["Parasite Epidemiology and Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673125000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673125000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:44:16Z","timestamp":1740761056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405673125000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":67,"alternative-id":["S2405673125000066"],"URL":"https:\/\/doi.org\/10.1016\/j.parepi.2025.e00413","relation":{},"ISSN":["2405-6731"],"issn-type":[{"value":"2405-6731","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of C\u03b2S and ODC antimony resistance markers in anthroponotic cutaneous leishmaniasis field isolates by gene expression profiling","name":"articletitle","label":"Article Title"},{"value":"Parasite Epidemiology and Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parepi.2025.e00413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.","name":"copyright","label":"Copyright"}],"article-number":"e00413"}}